Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reiter

Showing results (251-260 of 386) with videos related to

Pageof 39
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 1, 2010
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumorsEric J Lepin, Jeffrey V Leyton, Yu Zhou, et al.
Clinical Genitourinary Cancer|October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CTGiulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
Urologic Oncology|July 17, 2014
Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancerGeoffrey A Sonn, Christopher P Filson, Edward Chang, et al.
Current Oncology Reports|February 1, 2023
Multimodality Therapies for Localized Prostate CancerLuca F Valle, Tommy Jiang, Adam B Weiner, et al.
European Urology Oncology|September 22, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center StudyAndrew T Lenis, Aydin Pooli, Patrick M Lec, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2007
Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibodyTove Olafsen, Zhennan Gu, Mark A Sherman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center StudyIda Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancerR E Reiter, Z Gu, T Watabe, et al.
European Urology Oncology|November 9, 2025
Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical TrialRaag Agrawal, Adam B Weiner, Julie Livingstone, et al.
Nature Medicine|April 1, 1997
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID miceK A Klein, R E Reiter, J Redula, et al.
Pageof 39

Showing results (251-260 of 386) with videos related to

Sort By:
Pageof 39
European Journal of Nuclear Medicine and Molecular Imaging|April 1, 2010
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumorsEric J Lepin, Jeffrey V Leyton, Yu Zhou, et al.
Clinical Genitourinary Cancer|October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CTGiulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
Urologic Oncology|July 17, 2014
Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancerGeoffrey A Sonn, Christopher P Filson, Edward Chang, et al.
Current Oncology Reports|February 1, 2023
Multimodality Therapies for Localized Prostate CancerLuca F Valle, Tommy Jiang, Adam B Weiner, et al.
European Urology Oncology|September 22, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center StudyAndrew T Lenis, Aydin Pooli, Patrick M Lec, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2007
Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibodyTove Olafsen, Zhennan Gu, Mark A Sherman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center StudyIda Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancerR E Reiter, Z Gu, T Watabe, et al.
European Urology Oncology|November 9, 2025
Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical TrialRaag Agrawal, Adam B Weiner, Julie Livingstone, et al.
Nature Medicine|April 1, 1997
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID miceK A Klein, R E Reiter, J Redula, et al.
Pageof 39